FLOVID-20
COVID-19
A prophylactic needle-free nebulizer treatment to prevent COVID-19 in both virus-exposed and healthy patient populations. A unique targeted T-Cell immunotherapy biomedicine designed to help cure and prevent COVID-19.
FlowVax Ebola
Ebola
By relying on T-cells rather than antibodies, FlowVax Ebola provides long lasting protection through enhanced immune targeting and surveillance of the hidden Ebola virus nucleocapsid protein. FLOVID-20 targets the SARS-CoV-2 virus in the same way.
FlowVax Marburg
Marburg
Marburg is an Ebola-like virus suitable for weaponization by hostile forces. Working directly with the United States Dept. of Defense, we are developing FlowVax Marburg, a prophylactic nebulized biomedicine to protect at-risk military forces and civilians.
FlowVax BreastCA
Cancer
A revolutionary approach to breast cancer that utilizes T-cell biomedicines to provide highly efficacious therapy.
FlowVax HPV
Cancer, HPV
FlowVax-HPV is under development as a targeted T-cell immunotherapy for HPV induced squamous cell carcinomas of the head, neck, and cervix.